153 related articles for article (PubMed ID: 1655692)
21. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
[TBL] [Abstract][Full Text] [Related]
22. Positive inotropic and chronotropic effects of toborinone and its electrophysiological properties in the isolated hearts of rabbits and guinea-pigs.
Takase H; Orito K; Mori T; Fujiki H; Sekiguchi K; Tominaga M; Iijima T
Arzneimittelforschung; 1996 Jun; 46(6):579-86. PubMed ID: 8767347
[TBL] [Abstract][Full Text] [Related]
23. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N
J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754
[TBL] [Abstract][Full Text] [Related]
24. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
Ahn HS; Eardley D; Watkins R; Prioli N
Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
[TBL] [Abstract][Full Text] [Related]
25. Dissociation of cyclic AMP and contractile responses to isoprenaline: effects of a dihydropyridine derivative, nicardipine (YC-93), on canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N
Eur J Pharmacol; 1980 Oct; 67(2-3):225-33. PubMed ID: 6257529
[TBL] [Abstract][Full Text] [Related]
26. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.
Böhm M; Morano I; Pieske B; Rüegg JC; Wankerl M; Zimmermann R; Erdmann E
Circ Res; 1991 Mar; 68(3):689-701. PubMed ID: 1660359
[TBL] [Abstract][Full Text] [Related]
27. Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria.
Muller B; Lugnier C; Stoclet JC
J Cardiovasc Pharmacol; 1990 Mar; 15(3):444-51. PubMed ID: 1691369
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological characteristics of adenosine-induced inhibition of dog ventricular contractility: dependence on the pre-existing level of beta-adrenoceptor activation.
Endoh M; Kushida H; Norota I; Takanashi M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):70-8. PubMed ID: 1685559
[TBL] [Abstract][Full Text] [Related]
30. Inotropic and chronotropic effects of 4-(4'-n-butylaniline)-7,8- dimethoxy-5H-pyrimido[5,4-b]indole in guinea-pig atria.
Castiella E; Frechilla D; Lasheras B; Cenarruzabeitia E; Martínez de Irujo JJ; Alberdi E; Santiago E; Monge A; Villanueva A; Martinez FJ
J Pharm Pharmacol; 1995 Jul; 47(7):601-7. PubMed ID: 8568629
[TBL] [Abstract][Full Text] [Related]
31. Frequency modulation of the inotropic action of isoproterenol in mouse heart.
Barovsky K; Gross SR
J Pharmacol Exp Ther; 1981 May; 217(2):314-25. PubMed ID: 6262482
[TBL] [Abstract][Full Text] [Related]
32. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
Weishaar RE; Quade MM; Schenden JA; Evans DB
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
[TBL] [Abstract][Full Text] [Related]
33. Cholera toxin-induced changes in force of contraction and cyclic AMP levels in canine ventricular myocardium: inhibition by carbachol.
Endoh M; Maruyama M; Yanagisawa T
Life Sci; 1984 Dec; 35(24):2397-406. PubMed ID: 6096655
[TBL] [Abstract][Full Text] [Related]
34. Effects of alpha-adrenoceptor stimulation with phenylephrine in the presence of propranolol on force of contraction, slow inward current and cyclic AMP content in the bovine heart.
Brückner R; Scholz H
Br J Pharmacol; 1984 May; 82(1):223-32. PubMed ID: 6329389
[TBL] [Abstract][Full Text] [Related]
35. Decreased inotropic but relatively preserved relaxation response to cyclic adenosine monophosphate-dependent agents in myopathic human myocardium.
Gutstein DE; Flemmal K; Bruce E; Travers KE; Gwathmey JK; Ransil BJ; Markis JE; Grossman W; Morgan JP
J Card Fail; 1996 Dec; 2(4):285-92. PubMed ID: 8989643
[TBL] [Abstract][Full Text] [Related]
36. Cardiotonic activity of a new inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), in the dog with and without beta-blocker and Ca++-antagonist pretreatment.
Hori M; Inoue M; Tamai J; Koretsune Y; Kitakaze M; Iwai K; Ito H; Kitabatake A; Kamada T
Jpn Circ J; 1986 Jan; 50(1):37-44. PubMed ID: 3702034
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological and biochemical effects of the cardiotonic agent Org10325 in isolated cardiac and vascular tissue preparations.
Shahid M; Martorana MG; Cottney JE; Marshall RJ
Br J Pharmacol; 1990 Aug; 100(4):735-42. PubMed ID: 2169938
[TBL] [Abstract][Full Text] [Related]
38. Effects of the positive inotropic agent Org 30029 on developed force and aequorin light transients in intact canine ventricular myocardium.
Kawabata Y; Endoh M
Circ Res; 1993 Mar; 72(3):597-606. PubMed ID: 8431987
[TBL] [Abstract][Full Text] [Related]
39. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
[TBL] [Abstract][Full Text] [Related]
40. Cyclic AMP-dependent and cyclic AMP-independent actions of a novel cardiotonic agent, OPC-8212.
Rapundalo ST; Lathrop DA; Harrison SA; Beavo JA; Schwartz A
Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):692-8. PubMed ID: 2854217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
